BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esfahani MKM, Alavi SE, Cabot PJ, Islam N, Izake EL. PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 2021;13:1605. [PMID: 34683898 DOI: 10.3390/pharmaceutics13101605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Boshrouyeh R, Amari S, Boshrouyeh Ghandashtani M, Alavi SE, Ebrahimi Shahmabadi H. A topical gel nanoformulation of amphotericin B (AmB) for the treatment of cutaneous leishmaniasis (CL). J Sol-Gel Sci Technol 2023. [DOI: 10.1007/s10971-023-06041-w] [Reference Citation Analysis]
2 Qian Z, Zhang Y, Yuan J, Gong S, Chen B. Current applications of nanomaterials in urinary system tumors. Front Bioeng Biotechnol 2023;11:1111977. [PMID: 36890910 DOI: 10.3389/fbioe.2023.1111977] [Reference Citation Analysis]
3 Surov AO, Vasilev NA, Magdysyuk OV, Perlovich GL, Varlamova AI, Arkhipov IA, Odoevskaya IM. Structural features, dissolution performance and anthelmintic efficacy of multicomponent solid forms of fenbendazole with maleic and oxalic acids. CrystEngComm 2023. [DOI: 10.1039/d2ce01644c] [Reference Citation Analysis]
4 Bezerra GSN, Moritz VF, de Lima TADM, Colbert DM, Geever J, Geever L. Compatibility Study between Fenbendazole and Polymeric Excipients Used in Pharmaceutical Dosage Forms Using Thermal and Non-Thermal Analytical Techniques. Analytica 2022;3:448-461. [DOI: 10.3390/analytica3040031] [Reference Citation Analysis]
5 Alavi SE, Panah N, Page F, Gholami M, Dastfal A, Sharma LA, Ebrahimi Shahmabadi H. Hydrogel-based therapeutic coatings for dental implants. European Polymer Journal 2022;181:111652. [DOI: 10.1016/j.eurpolymj.2022.111652] [Reference Citation Analysis]
6 Alavi SE, Raza A, Koohi Moftakhari Esfahani M, Akbarzadeh A, Abdollahi SH, Ebrahimi Shahmabadi H. Carboplatin Niosomal Nanoplatform for Potentiated Chemotherapy. J Pharm Sci 2022;111:3029-37. [PMID: 35675875 DOI: 10.1016/j.xphs.2022.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Alavi SE, Raza A, Gholami M, Giles M, Al-sammak R, Ibrahim A, Ebrahimi Shahmabadi H, Sharma LA. Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens. Pharmaceutics 2022;14:2293. [DOI: 10.3390/pharmaceutics14112293] [Reference Citation Analysis]
8 Ghaferi M, Raza A, Koohi M, Zahra W, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics 2022;14:2183. [DOI: 10.3390/pharmaceutics14102183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Alavi SE, Bakht U, Koohi Moftakhari Esfahani M, Adelnia H, Abdollahi SH, Ebrahimi Shahmabadi H, Raza A. A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics. Pharmaceutics 2022;14:1668. [DOI: 10.3390/pharmaceutics14081668] [Reference Citation Analysis]
10 Tiburcius S, Krishnan K, Jose L, Patel V, Ghosh A, Sathish CI, Weidenhofer J, Yang JH, Verrills NM, Karakoti A, Vinu A. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells. Nanoscale 2022;14:6830-45. [PMID: 35441642 DOI: 10.1039/d2nr00783e] [Reference Citation Analysis]
11 Koohi Moftakhari Esfahani M, Alavi SE, Cabot PJ, Islam N, Izake EL. β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics 2022;14:884. [PMID: 35456716 DOI: 10.3390/pharmaceutics14040884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Bezerra GSN, Colbert DM, O’donnell C, Cao Z, Geever J, Geever L. Compatibility Study Between Fenbendazole and Poly(Ethylene Oxide) with Application in Solid Dispersion Formulations Using Hot-Melt Extrusion. J Pharm Innov. [DOI: 10.1007/s12247-022-09644-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ghaferi M, Zahra W, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Enhancing the efficacy of albendazole for liver cancer treatment using mesoporous silica nanoparticles: an in vitro study. EXCLI J 2022;21:236-49. [PMID: 35221842 DOI: 10.17179/excli2021-4491] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Alavi SE, Esfahani MKM, Raza A, Adelnia H, Shahmabadi HE. PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study. NanoImpact 2022. [DOI: 10.1016/j.impact.2022.100384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]